Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: An in vitro proton (1H) MR spectroscopy study

Magnetic Resonance Imaging

Volumn 28, Issue 7, 2010, Pages 1022-1029

  Sharma, Uma ^a   Singh, Rajiv R ^a   Ahuja, Vineet ^a   Makharia, Govind K ^a   Jagannathan, Naranamangalam R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Crohn's disease; Inflammatory bowel disease; Involved and un involved mucosa; Metabolite concentration; Ulcerative colitis

Indexed keywords

ALANINE; AMINO ACID; ARGININE; CHOLINE; FORMIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LYSINE; PHOSPHORYLCHOLINE; VALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; ENTERITIS; FEMALE; HUMAN; HYPOTHESIS; IN VITRO STUDY; MALE; METABOLITE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE METABOLISM;

EID: 77955421235     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.039     Document Type: Article

References (33)

1. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
2. Travis S.P.L., Stange E.F., Lemann M., et al. European evidence-based consensus on the management of ulcerative colitis: Current management. J Crohn's Colitis 2008, 2:24-62.
3. Mathy C., Schneider K., Chen Y.Y., et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis 2003, 9:351-355.
4. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
5. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
6. Langholz E., Munkholm P., Davidsen M., et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996, 31:260-266.
7. Moum B., Ekbom A., Vatn M.H., et al. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999, 94:1564-1569.
8. Sharma U., Atri S., Sharma M.C., et al. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging 2003, 21:145-153.
9. Gribbestad I.S., Petersen S.B., Fjøsne H.E., et al. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994, 7:181-194.
10. 1H magnetic resonance spectroscopy: a pilot study. Magn Reson Imaging 2004, 22:697-706.
11. 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed 1996, 9:33-45.
12. 1H-NMR-based metabonomics. Nat Med 2002, 8:1439-1444.
13. 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol 2001, 96:442-448.
14. Marchesi J.R., Holmes E., Khan F., et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007, 6:546-551.
15. Balasubramanian K., Kumar S., Singh R.R., et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in-vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging 2009, 27:79-86.
16. Best W.R., Becktel J.M., Singleton J.W., et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
17. Silverberg M.S., Satsangi J., Ahmad T. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19A:5-36.
18. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, 2:1041-1048.
19. Sharma U., Chaudhury K., Jagannathan N.R., et al. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction 2001, 122:431-436.
20. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994, 35(1 Suppl):S35-S38.
21. Ahmad M.S., Krishnan S., Ramakrishna B.S., et al. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 2000, 46:493-499.
22. Binder H.J., Mehta P. Short-chain fatty acids stimulate active sodium and chloride absorption in-vitro in the rat distal colon. Gastroenterology 1989, 96:989-996.
23. Finnie I.A., Dwarakanath A.D., Taylor B.A., et al. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995, 36:93-99.
24. Roediger W.E., Kapaniris O., Millard S. Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis. Mol Cell Biochem 1992, 118:113-118.
25. Roediger W.E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982, 83:424-429.
26. Ardawi M.S., Newsholme E.A. Fuel utilization in colonocytes of the rat. Biochem J 1985, 231:713-719.
27. Firmansyah A., Penn D., Lebenthal E. Isolated colonocyte metabolism of glucose, glutamine, n-butyrate, and beta-hydroxybutyrate in malnutrition. Gastroenterology 1989, 97:622-629.
28. Faintuch J. Nutritional abnormalities in inflammatory bowel disease. Rev Hosp Clin Fac Med Sao Paulo 2002, 57:129-130.
29. Smith R.J. Glutamine metabolism and its physiologic importance. JPEN J Parenter Enteral Nutr 1990, 14(4 Suppl):40S-44S.
30. Windmueller H.G. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol 1982, 53:201-237.
31. Michel V., Yuan Z., Ramsubir S., et al. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood) 2006, 231:490-504.
32. Holub B.J. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr 1986, 6:563-597.
33. Gassull M.A. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis 2003, 21:220-227.